Literature DB >> 29230145

Practical Issues in the Management of Overt Hepatic Encephalopathy.

Ganesh Pantham1, Kevin D Mullen1.   

Abstract

Hepatic encephalopathy (HE) is a condition that encompasses a range of neuropsychiatric abnormalities in patients with significant liver disease. Overt HE occurs in approximately 30% to 45% of patients with cirrhosis. This article discusses practical issues in the management of patients with overt HE and cirrhosis, including a recently developed 4-pronged approach that consists of identifying and correcting precipitating factors, recognizing and treating concomitant medical conditions, commencing empiric treatment, and caring for the unconscious patient. Following recovery from overt HE, a plan of action should be developed to prevent readmissions.

Entities:  

Keywords:  Cirrhosis; covert hepatic encephalopathy; overt hepatic encephalopathy

Year:  2017        PMID: 29230145      PMCID: PMC5717881     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  73 in total

1.  Cerebral resuscitation: role of osmotherapy.

Authors:  Izumi Harukuni; Jeffrey R Kirsch; Anish Bhardwaj
Journal:  J Anesth       Date:  2002       Impact factor: 2.078

2.  Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

Authors:  Rafael Bañares; Frederik Nevens; Fin Stolze Larsen; Rajiv Jalan; Agustín Albillos; Matthias Dollinger; Faouzi Saliba; Tilman Sauerbruch; Sebastian Klammt; Johann Ockenga; Albert Pares; Julia Wendon; Tanja Brünnler; Ludwig Kramer; Philippe Mathurin; Manuel de la Mata; Antonio Gasbarrini; Beat Müllhaupt; Alexander Wilmer; Wim Laleman; Martin Eefsen; Sambit Sen; Alexander Zipprich; Teresa Tenorio; Marco Pavesi; Hartmut H-J Schmidt; Steffen Mitzner; Roger Williams; Vicente Arroyo
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

Review 3.  Branched-chain amino acids as pharmacological nutrients in chronic liver disease.

Authors:  Takumi Kawaguchi; Namiki Izumi; Michael R Charlton; Michio Sata
Journal:  Hepatology       Date:  2011-06-23       Impact factor: 17.425

4.  Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.

Authors:  G Marchesini; A Fabbri; G Bianchi; M Brizi; M Zoli
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

5.  Low likelihood of intracranial hemorrhage in patients with cirrhosis and altered mental status.

Authors:  Lucas M Donovan; Whitney L Kress; Luke C Strnad; Ammar Sarwar; Vilas Patwardhan; Gail Piatkowski; Elliot B Tapper; Nezam H Afdhal
Journal:  Clin Gastroenterol Hepatol       Date:  2014-06-04       Impact factor: 11.382

6.  Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis.

Authors:  Samuel H Sigal; Carmen M Stanca; Nickolas Kontorinis; Carol Bodian; Elizabeth Ryan
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

7.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

8.  Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft.

Authors:  Fabrizio Fanelli; Filippo Maria Salvatori; Paolo Rabuffi; Emanuele Boatta; Oliviero Riggio; Pierleone Lucatelli; Roberto Passariello
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

9.  Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.

Authors:  Barjesh Chander Sharma; Praveen Sharma; Amit Agrawal; Shiv Kumar Sarin
Journal:  Gastroenterology       Date:  2009-06-06       Impact factor: 22.682

10.  Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.

Authors:  E Strauss; R Tramote; E P Silva; W R Caly; N Z Honain; R A Maffei; M F de Sá
Journal:  Hepatogastroenterology       Date:  1992-12
View more
  5 in total

Review 1.  Management of Hepatic Encephalopathy Not Responsive to First-Line Treatments.

Authors:  Silvia Nardelli; Lorenzo Ridola; Stefania Gioia; Oliviero Riggio
Journal:  Curr Treat Options Gastroenterol       Date:  2018-06

Review 2.  Clinical management of type C hepatic encephalopathy.

Authors:  Lorenzo Ridola; Oliviero Riggio; Stefania Gioia; Jessica Faccioli; Silvia Nardelli
Journal:  United European Gastroenterol J       Date:  2020-02-26       Impact factor: 4.623

Review 3.  Hepatic Encephalopathy: Diagnosis and Management.

Authors:  Lorenzo Ridola; Jessica Faccioli; Silvia Nardelli; Stefania Gioia; Oliviero Riggio
Journal:  J Transl Int Med       Date:  2020-12-31

4.  Differentiation of hepatic encephalopathy from delirium tremens: A case series and review.

Authors:  Spandana Devabhaktuni; Prajakta Patkar; V Pooja; Sana Dhamija; Nishtha Gupta; Suprakash Chaudhury; Daniel Saldanha
Journal:  Ind Psychiatry J       Date:  2021-10-22

5.  Feasibility, Efficacy, and Safety of Percutaneous Muscle Biopsies in Patients With Chronic Liver Disease.

Authors:  Jonathan I Quinlan; Amritpal Dhaliwal; Felicity Williams; Sophie L Allen; Leigh Breen; Carolyn A Greig; Janet M Lord; Matthew J Armstrong; Ahmed M Elsharkawy
Journal:  Front Physiol       Date:  2022-02-15       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.